Watchdog: NHS-Branded Baby Formula May Save Parents From Overpaying
Parents tend to choose a pricier option under the assumption that a higher cost implies better quality, according to market analysis findings.
An upcoming product, bearing the NHS brand, might soon grace supermarket shelves, providing parents with a more budget-friendly alternative compared to current offerings from established manufacturers.
The UK Competition and Markets Authority noted on Thursday that the baby formula market requires a revamp, as prices are too steep for many families. The interim report by the watchdog highlighted limited competition in formula pricing at retail outlets.
Sarah Cardell, the Chief Executive of the CMA, expressed concerns in a statement: “This market is of utmost importance and unique. We’re worried that companies are not engaging in robust price competition, leading many parents—who might be making formula choices in challenging circumstances and lacking clear information—to lean towards pricier options, associating higher costs with superior quality for their baby.”
The UK baby formula market is heavily dominated by three manufacturers—Danone, Kendal, and Nestle—collectively controlling 90–100 percent of the supply.
The report indicated an increase in prices for infant formula powder by 18–36 percent between December 2021 and December 2023. It also mentioned that manufacturers have minimal motivation to compete on price, swiftly passing on cost rises to consumers.
The watchdog’s findings also reveal that parents commonly opt for a more expensive product, assuming a higher price correlates with better quality.
“This is despite NHS advice that ‘It does not matter which brand you choose, they’ll all meet your baby’s nutritional needs, regardless of price’,” the CMA noted.
The market may see interventions to regulate prices, including the potential introduction of baby formula under the NHS brand. The procurement contract for the product could involve a third-party manufacturer offering competitive pricing.
“This move would introduce more options for parents at lower prices. Consequently, it could exert downward pressure on prices from other manufacturers,” as per the report.
“Too many parents are coerced into paying excessive amounts when they are most vulnerable. More measures must be implemented to safeguard those facing difficulties,” stated Jarvis.
Recommendations
The CMA laid out several suggestions to enhance sector competitiveness and alleviate financial burdens on parents. The authority called for clear and accurate nutritional messaging on baby formula products.
Parents should have a broader array of options, including standardized hospital packaging, to diminish brand influence, the report emphasized.
Manufacturers were urged to adhere to stringent criteria for the messages exhibited on infant and follow-on formula products, it further stated.
While considering a potential price cap, the CMA refrained from endorsing one outright. It will review feedback on its recommendations and collaborate closely with the government before releasing the final report in February 2025.
In response to the CMA’s report, the First Steps Nutrition Trust and the Baby Feeding Law Group UK released a statement, calling for immediate action to shield families from escalating costs.
Advocates pushed for a substantial price intervention, like imposing a cap on infant formula prices.
“Nevertheless, we caution against encouraging price competition through publicizing prices and discounts, as international evidence suggests this encourages purchases and undermines breastfeeding,” added the statement.
Anna Taylor, the charity’s executive director, revealed that one in four mothers struggle to afford first infant formula.
“First infant formula is absolutely essential for those families dependent on it, yet we know that one in four mothers struggle to afford it.
“This is too important to be left to the market. We need the government to step in and ensure that first infant formula is affordable for those who require it,” Taylor insisted.